Latest Artificial pancreas Stories
DANBURY, Conn., May 10, 2011 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today that an independent investigator initiated a pump trial of Biodel's two ultra-rapid-acting formulations of recombinant human insulin.
WIESBADEN, Germany, May 10, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has received CE Mark (Conformite Europeenne) for its new FreeStyle InsuLinx Blood Glucose Monitoring System,(1,2) the first blood glucose monitoring device from Abbott that includes a mealtime (bolus) insulin calculator for calculating suggested insulin doses.
Decreasing blood levels of a protein that helps control inflammation may be a red flag that could help children avoid type 1 diabetes, researchers say.
Two small randomised trials published on bmj.com today suggest that closed loop insulin delivery (also known as an artificial pancreas) may improve overnight blood glucose control and reduce the risk of nocturnal hypoglycaemia (a sudden drop in blood glucose levels during the night) in adults with type 1 diabetes.
Johns Hopkins researchers believe they have uncovered the molecular switch for the secretion of insulin â€” the hormone that regulates blood sugar â€” providing for the first time an explanation of this process.
About 1 million people are affected by type 1 diabetes in the United States.
Parents and Clinicians to Learn About the Challenges and Opportunities of Raising a Child With Type 1 Diabetes at Free Juvenile Diabetes Research Foundation Summit Washington, DC (PRWEB) January 24, 2011 On Saturday, January 29th, hundreds of parents and clinicians from up and down the East Cost will have the opportunity to hear first-hand from some of the countryâ€™s most prominent researchers about the latest developments in the prevention, management and cure of type 1 diabetes.
ALAMEDA, Calif., Dec.
A Statement from JDRF President and CEO, Jeffrey Brewer NEW YORK, Dec. 9, 2010 /PRNewswire-USNewswire/ -- "Today Congress passed a multi-year renewal of the Special Diabetes Program (SDP), ensuring that studies on promising diabetes treatments and avenues toward a cure continue uninterrupted.
DANBURY, Conn., Nov. 12, 2010 /PRNewswire/ -- Scientists from Biodel Inc.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.
More Images (1 images) »